| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
GKOS
Glaukos
|
Oct 30, 2026 | BUY |
Strong Buy
-18.6% avg upside
21 analysts
|
$248.00
4.38% Upside
|
-5.5% | · |
|
AXGN
AxoGen
|
Oct 29, 2026 | BUY |
Strong Buy
-17.4% avg upside
21 analysts
|
$56.00
13.37% Upside
|
-1.8% | · |
|
ANIX
Anixa Biosciences
|
Oct 27, 2026 | BUY |
Strong Buy
+220.5% avg upside
4 analysts
|
$6.00
92.23% Upside
|
-8.8% | · |
|
OPK
Opko Health
|
Oct 27, 2026 | BUY |
Buy
+284.6% avg upside
12 analysts
|
$3.00
80.65% Upside
|
+3.1% | · |
|
TEM
Tempus AI, Inc. Class A
|
Oct 26, 2026 | BUY |
Buy
-0.3% avg upside
25 analysts
|
$68.00
5.94% Downside
|
+13.2% | · |
|
BDSX
Biodesix
|
Oct 22, 2026 | BUY |
Strong Buy
+61.4% avg upside
9 analysts
|
$38.00
63.35% Upside
|
-17.1% | · |
|
SGP
SpyGlass Pharma
|
Oct 21, 2026 | BUY |
Strong Buy
+36.5% avg upside
6 analysts
|
$37.00
14.77% Upside
|
+33.4% | · |
|
OCUL
Ocular Therapeutix
|
Oct 20, 2026 | BUY |
Strong Buy
+253.9% avg upside
21 analysts
|
$25.00
258.58% Upside
|
-3.3% | · |
|
OCS
Oculis Holding
|
Oct 20, 2026 | BUY |
Strong Buy
+367.8% avg upside
11 analysts
|
$39.00
372.23% Upside
|
+0.0% | · |
|
DRTS
Alpha Tau
|
Oct 20, 2026 | BUY |
Strong Buy
+7.2% avg upside
5 analysts
|
$16.00
22.47% Upside
|
+4.8% | · |
|
EYPT
EyePoint Pharmaceuticals
|
Oct 20, 2026 | HOLD |
Buy
+3222.9% avg upside
21 analysts
|
— | -12.2% | · |
|
BLTE
Belite Bio, Inc. ADR
|
Oct 15, 2026 | BUY |
Strong Buy
+29.7% avg upside
11 analysts
|
$245.00
58.27% Upside
|
+0.7% | · |
|
SGHT
Sight Sciences
|
Oct 15, 2026 | BUY |
Strong Buy
+9.7% avg upside
14 analysts
|
$14.00
50.26% Upside
|
+7.0% | · |
|
ANGO
AngioDynamics
|
Oct 14, 2026 | BUY |
Strong Buy
+47.1% avg upside
9 analysts
|
$18.00
50.05% Upside
|
+6.2% | · |
|
DE:FYB
Formycon AG
|
Oct 14, 2026 | BUY |
Strong Buy
+171.1% avg upside
5 analysts
|
$42.00
122.38% Upside
|
-2.9% | · |
|
COCH
Envoy Medical
|
Oct 13, 2026 | BUY |
Strong Buy
+52.8% avg upside
5 analysts
|
$2.00
69.90% Downside
|
+8.5% | · |
|
OKYO
OKYO Pharma Limited Sponsored ADR
|
Oct 06, 2026 | BUY |
Strong Buy
+410.2% avg upside
4 analysts
|
$5.00
240.22% Upside
|
-0.7% | · |
|
BEAT
HeartBeam
|
Oct 06, 2026 | HOLD |
Buy
+647.3% avg upside
14 analysts
|
— | -31.2% | · |
|
OBIO
Orchestra BioMed Holdings
|
Oct 05, 2026 | BUY |
Strong Buy
+120.0% avg upside
10 analysts
|
$10.00
69.30% Upside
|
-2.0% | · |
|
RGNX
RegenXBio
|
Sep 25, 2026 | BUY |
Strong Buy
+389.8% avg upside
25 analysts
|
$21.00
191.69% Upside
|
+3.8% | · |
|
LPCN
Lipocine
|
Sep 22, 2026 | HOLD |
Strong Buy
+907.0% avg upside
4 analysts
|
$4.00
177.71% Upside
|
-34.3% | · |
|
LFMD
LifeMD
|
Sep 18, 2026 | BUY |
Strong Buy
+338.6% avg upside
14 analysts
|
$9.00
293.10% Upside
|
-26.4% | · |
|
BLCO
Bausch + Lomb Corporation
|
Aug 28, 2026 | BUY |
Buy
+7.6% avg upside
20 analysts
|
$21.00
5.00% Upside
|
+16.2% | · |
|
NPCE
NeuroPace
|
Aug 13, 2026 | BUY |
Strong Buy
+46.9% avg upside
14 analysts
|
$20.00
62.69% Upside
|
-15.2% | · |
|
HROW
Harrow Health
|
Aug 12, 2026 | BUY |
Strong Buy
+85.9% avg upside
13 analysts
|
$70.00
147.93% Upside
|
-33.8% | · |
|
APYX
Apyx Medical
|
Aug 07, 2026 | BUY |
Strong Buy
+852.0% avg upside
12 analysts
|
$7.00
169.25% Upside
|
-24.4% | · |
|
CDNA
CareDx
|
Jul 31, 2026 | HOLD |
Buy
-41.0% avg upside
18 analysts
|
$46.00
47.39% Downside
|
+79.7% | · |
|
SMTI
Sanara MedTech
|
Jul 30, 2026 | HOLD |
Buy
+19.4% avg upside
5 analysts
|
$35.00
6.71% Upside
|
-7.4% | · |
|
GLSI
Greenwich LifeSciences
|
Jul 21, 2026 | BUY |
Strong Buy
+227.5% avg upside
2 analysts
|
$69.00
296.37% Upside
|
+12.3% | · |
|
VANI
Vivani Medical
|
Jul 09, 2026 | BUY |
Strong Buy
+299.4% avg upside
6 analysts
|
$3.50
221.18% Upside
|
-33.3% | · |
|
DE:2SE
Sequana Medical N.V
|
Jul 06, 2026 | HOLD |
Hold
1 analyst
|
— | · | · |
|
PMI
Picard Medical, Inc.
|
Jun 04, 2026 | HOLD |
Hold
1 analyst
|
— | · | · |
|
VVOS
Vivos Therapeutics
|
Apr 17, 2026 | BUY |
Strong Buy
+16398.2% avg upside
4 analysts
|
$2.50
2096.77% Upside
|
-88.3% | · |
|
BNGO
BioNano Genomics
|
Apr 13, 2026 | BUY |
Buy
+722.6% avg upside
9 analysts
|
$6.00
421.65% Upside
|
+0.9% | · |
|
VNRX
VolitionRX
|
Apr 02, 2026 | BUY |
Strong Buy
+4956.3% avg upside
11 analysts
|
$20.00
10140.58% Upside
|
-94.4% | · |
|
VRAX
Virax Biolabs Group Ltd. Class A
|
Jan 09, 2026 | BUY |
Strong Buy
-17.3% avg upside
1 analyst
|
$1.00
17.33% Downside
|
· | · |
|
VERU
Veru
|
Dec 31, 2025 | HOLD |
Strong Buy
+838.3% avg upside
11 analysts
|
— | -0.9% | · |
|
LEXX
Lexaria Bioscience
|
Dec 26, 2025 | BUY |
Strong Buy
+129.4% avg upside
3 analysts
|
$1.50
56.98% Downside
|
-49.4% | · |
|
CODX
Co-Diagnostics
|
Nov 24, 2025 | HOLD |
Buy
+4968.0% avg upside
5 analysts
|
— | -96.3% | · |
|
ELDN
Eledon Pharmaceuticals
|
Nov 10, 2025 | BUY |
Strong Buy
+460.9% avg upside
11 analysts
|
$9.00
224.97% Upside
|
+16.4% | · |
|
EDSA
Edesa Biotech
|
Nov 03, 2025 | BUY |
Strong Buy
+334.5% avg upside
6 analysts
|
$5.00
94.54% Upside
|
+40.2% | · |
|
ICCM
Icecure Medical
|
Oct 07, 2025 | BUY |
Strong Buy
+4299.5% avg upside
5 analysts
|
$75.00
8519.67% Upside
|
· | · |
|
KALA
KALA BIO
|
Sep 29, 2025 | HOLD |
Strong Buy
+125847.8% avg upside
9 analysts
|
— | · | · |
|
KPRX
Kiora Pharmaceuticals
|
Sep 02, 2025 | BUY |
Strong Buy
+473.7% avg upside
6 analysts
|
$10.00
540.97% Upside
|
-39.2% | · |
|
SRTS
Sensus Healthcare
|
Aug 12, 2025 | BUY |
Buy
+137.8% avg upside
8 analysts
|
$8.00
189.94% Upside
|
-12.5% | · |
|
QUCY
Quantum Cyber
|
Jul 25, 2025 | HOLD |
Buy
+376.2% avg upside
4 analysts
|
— | -58.8% | · |
|
GRDX
GridAI Technologies
|
Apr 11, 2025 | HOLD |
Strong Buy
+291.9% avg upside
7 analysts
|
— | +308.6% | · |
|
RNLXY
Renalytix
|
Nov 07, 2024 | HOLD |
Strong Buy
+190.7% avg upside
5 analysts
|
— | · | · |
|
MBAI
MBody AI Ltd
|
Sep 06, 2024 | HOLD |
Strong Buy
+365.4% avg upside
6 analysts
|
— | · | · |
|
PRPH
Prophase Labs
|
Aug 27, 2024 | HOLD |
Sell
2 analysts
|
— | · | · |
|
BNBX
BNB Plus
|
Jun 10, 2024 | BUY |
Buy
+10824.0% avg upside
5 analysts
|
$1.50
1521.72% Upside
|
· | · |
|
GNPX
Genprex
|
May 17, 2024 | BUY |
Strong Buy
+234.8% avg upside
5 analysts
|
$10.00
346.38% Upside
|
· | · |
|
CFOR
CapForce
|
Mar 22, 2024 | HOLD |
Buy
+115.4% avg upside
3 analysts
|
— | · | · |
|
MOTS
Motus Gi Holdings
|
Mar 14, 2024 | HOLD |
Strong Buy
+453416.8% avg upside
6 analysts
|
— | · | · |
|
NMRD
Nemaura Medical
|
Jan 08, 2024 | HOLD |
Strong Buy
+3749900.0% avg upside
3 analysts
|
— | · | · |
|
HTGMQ
HTG Molecular Diagnostics
|
Nov 09, 2023 | HOLD |
Strong Buy
+733333233.4% avg upside
6 analysts
|
— | · | · |
|
GB:0G99
Oxurion NV
|
Jun 26, 2023 | HOLD |
Hold
+962.4% avg upside
2 analysts
|
— | · | · |
|
BPTH
Bio-Path Holdings
|
Mar 27, 2023 | HOLD |
Strong Buy
+2766566.7% avg upside
6 analysts
|
— | · | · |
|
IDXG
Interpace Diagnostics Group
|
Mar 27, 2023 | HOLD |
Strong Buy
+113.9% avg upside
9 analysts
|
— | +7.5% | · |
|
XRAY
DENTSPLY SIRONA
|
Apr 22, 2022 | HOLD |
Buy
+182.4% avg upside
25 analysts
|
$48.00
403.76% Upside
|
-23.4% | · |
|
CELC
Celcuity
|
May 11, 2021 | BUY |
Strong Buy
+82.7% avg upside
18 analysts
|
$30.00
56.52% Downside
|
-62.5% | · |
|
HYPD
Hyperion DeFi
|
Apr 01, 2021 | BUY |
Strong Buy
+161.7% avg upside
8 analysts
|
$8.00
148.42% Upside
|
· | · |
|
WHWK
Whitehawk Therapeutics
|
Mar 15, 2021 | HOLD |
Strong Buy
+274.2% avg upside
15 analysts
|
— | -67.4% | · |
|
CYDY
CytoDyn
|
Mar 09, 2021 | HOLD |
Buy
+581.9% avg upside
2 analysts
|
— | -81.7% | · |
|
OGEN
Oragenics
|
Apr 16, 2020 | HOLD |
Buy
+301.1% avg upside
3 analysts
|
— | · | · |
|
TTOO
T2 Biosystems
|
Nov 21, 2019 | HOLD |
Buy
+1015078.6% avg upside
10 analysts
|
— | · | · |
|
SEELQ
Seelos Therapeutics
|
May 10, 2019 | BUY |
Buy
+4638571328.5% avg upside
10 analysts
|
$4.00
399999899.93% Upside
|
· | · |
|
VRDN
Viridian Therapeutics
|
Aug 19, 2016 | BUY |
Strong Buy
+42.6% avg upside
32 analysts
|
$4.00
83.70% Downside
|
-17.7% | · |
|
BIOCQ
Biocept
|
Aug 03, 2016 | BUY |
Strong Buy
+8407499899.9% avg upside
7 analysts
|
$2.50
249999899.94% Upside
|
· | · |
|
GALT
Galectin Therapeutics
|
Mar 03, 2016 | BUY |
Strong Buy
+193.7% avg upside
8 analysts
|
$7.00
110.92% Upside
|
+227.4% | · |
|
EOCN
Eocene
|
Mar 02, 2016 | BUY |
Buy
+688.3% avg upside
13 analysts
|
$21.00
577.41% Upside
|
· | · |
|
INO
Inovio Pharmaceuticals
|
Feb 17, 2016 | BUY |
Buy
+1300.8% avg upside
19 analysts
|
$17.00
2722.00% Upside
|
· | · |
|
LSTA
Lisata Therapeutics
|
Jan 08, 2016 | HOLD |
Buy
+1169.6% avg upside
11 analysts
|
— | · | · |
|
NSPR
InspireMD
|
Jan 07, 2016 | BUY |
Strong Buy
+665.6% avg upside
8 analysts
|
$4.00
788.96% Upside
|
· | · |
|
LADX
LadRx
|
Jan 23, 2015 | BUY |
Strong Buy
+64445.5% avg upside
5 analysts
|
$12.00
108990.98% Upside
|
· | · |
|
ARCT
Arcturus Therapeutics
|
Nov 17, 2014 | HOLD |
Buy
+175.7% avg upside
36 analysts
|
— | -37.1% | · |
|
ERINQ
Erin Energy
|
Sep 30, 2014 | BUY |
Strong Buy
+899999900.1% avg upside
1 analyst
|
$9.00
899999900.08% Upside
|
· | · |
|
TCOM
Trip.com Group Sponsored ADR
|
Aug 01, 2014 | HOLD |
Strong Buy
+47.9% avg upside
33 analysts
|
$66.00
66.65% Upside
|
+37.5% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.